A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2011
11/02/2011	CN101837083B Ointment for curing burns and scalds and preparation method thereof
11/02/2011	CN101732447B External Chinese medicinal composition for treating psoriasis and preparation method thereof
11/02/2011	CN101716224B Externally applied powder for treating burns, scalds and wounds
11/02/2011	CN101647844B Vinegar milk essence micro effervescent granules and preparation method thereof
11/02/2011	CN101530462B Composition for treating eczema and preparation method thereof
11/02/2011	CN101415731B Novel low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition, and food composition each using same
11/02/2011	CN101327002B Health care food for beauty treatment and face nursing
11/02/2011	CN101249198B Liniment for curing extremity tinea and onychomycosis
11/02/2011	CN101190263B Rhubarb chewable tablets and preparation method and application thereof
11/02/2011	CN101073537B Fine emulsion of oil in water
11/02/2011	CN101014708B Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
11/01/2011	US8048993 Heparanase specific molecular probes and their use in research and medical applications
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048911 Melanin eliminator preparation
11/01/2011	US8048890 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
11/01/2011	US8048873 Synergistic pharmaceutical combination for the prevention or treatment of diabetes
11/01/2011	CA2492976C Solution for ungual and peri-ungual application
11/01/2011	CA2488834C Purine derivatives and their use as antiproliferative agents
11/01/2011	CA2475224C Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2468826C Benzazole derivatives for the treatment of scleroderma
11/01/2011	CA2466418C Lipoxin a4 analogs
11/01/2011	CA2458534C Phenethanolamine derivatives for treatment of respiratory diseases
11/01/2011	CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
11/01/2011	CA2402247C Biodegradable immunomodulatory formulations and methods for use thereof
11/01/2011	CA2395459C Use of quinoline and quinolizinone derivatives as chemotherapeutic agents
10/2011
10/27/2011	WO2011133064A1 Method for producing an agent for eliminating skin defects and for treating wounds in the form of a gel based on water-soluble plant-derived polysaccharides
10/27/2011	WO2011132986A2 Therapeutic composition comprising extract of phragmitis rhizoma as active ingredient, for moisturizing skin and treating dermatitis or atopic dermatitis
10/27/2011	WO2011132177A1 Compounds provided with antioxidant activity against free radicals, and pharmaceutical and cosmetic compositions containing them
10/27/2011	WO2011132085A2 Methods and compositions for treating fibrosis
10/27/2011	WO2011131439A1 Cosmetic or dermatological preparations comprising combinations of magnolia bark extract and alkyl sulphates
10/27/2011	WO2011131026A1 Furo[3, 2-g]chromene compounds and uses thereof
10/27/2011	WO2011130800A1 Eczema treatment
10/27/2011	WO2011130788A1 Combined method for improving the health of skin
10/27/2011	WO2011130787A1 Method for improving the health of skin
10/27/2011	WO2011072103A3 Glycerine based jelly compositions
10/27/2011	WO2011060390A3 Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
10/27/2011	US20110263721 Aryl di-substituted propenone compounds
10/27/2011	US20110263714 Reverse Vesicle
10/27/2011	US20110263712 Process for the preparation of vorinostat
10/27/2011	US20110263698 Proanthocyanidin of cashew apple, composition containing proanthocyanidin, and application thereof
10/27/2011	US20110263695 NFAT Signal Inhibitor and Hair-Growing Agent
10/27/2011	US20110263692 Therapeutic compounds
10/27/2011	US20110263691 Methods concerning ppar delta and antagonists thereof
10/27/2011	US20110263684 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
10/27/2011	US20110263677 Gos2 modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011	US20110263676 Small interfering rna for gene knockdown of the subcutaneous n-methyl-d-aspartate receptor nr1 subunit, and it's application on pharmaceutics
10/27/2011	US20110263661 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
10/27/2011	US20110263659 Analogs of 1-Methylnicotinamide
10/27/2011	US20110263650 Tubulysin D Analogues
10/27/2011	US20110263646 Pharmaceutical topical compositions
10/27/2011	US20110263637 Up to six weeks dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod
10/27/2011	US20110263636 3 x 3 x 3 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMOD
10/27/2011	US20110263635 Method of treating actinic keratosis with 3.75% imiquimod cream
10/27/2011	US20110263634 Lower dosage strength pharmaceutical compositions formulated with 2.5% imiquimod
10/27/2011	US20110263633 Up to six weeks treatment regimen for treating actinic keratoses with pharmaceutical compositions formulated with 2.5% imiquimod
10/27/2011	US20110263628 N-hydroxyamide derivatives and use thereof
10/27/2011	US20110263612 Compounds that modulate intracellular calcium
10/27/2011	US20110263610 Compounds and compositions as itpkb inhibitors
10/27/2011	US20110263607 Alpha helix mimetics in the treatment of cancer
10/27/2011	US20110263597 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/27/2011	US20110263594 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
10/27/2011	US20110263593 NOVEL IMIDAZO[1,2-a]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE, IN PARTICULAR AS MET INHIBITORS
10/27/2011	US20110263589 Method for preventing or treating a glucocorticoid receptor-related disease
10/27/2011	US20110263583 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1
10/27/2011	US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011	US20110263577 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use
10/27/2011	US20110263568 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
10/27/2011	US20110263561 Novel pyrrolidone derivatives for use as MetAP-2 inhibitors
10/27/2011	US20110263552 Modulation of side effect profile of 5-alpha reductase inhibitor therapy
10/27/2011	US20110263547 C-19 steroids for specific therapeutic uses
10/27/2011	US20110263528 Antimicrobial compositions
10/27/2011	US20110263521 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
10/27/2011	US20110263519 Regulators of the hedgehog pathway, compositions and uses related thereto
10/27/2011	US20110263509 Preparation and use of high-purity hemoparatide (hpth-1-37) for the treatment of inflammatory scaling diseases of the skin
10/27/2011	US20110263508 Compositions and methods for including melanogenesis in a subject
10/27/2011	US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011	US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011	US20110263486 Inhibitors of Cancer Cell, T-Cell and Keratinocyte Proliferation
10/27/2011	US20110263478 Sur1 inhibitors for therapy
10/27/2011	US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011	US20110262562 Aqueous saline solutions for the destruction of fatty tissue
10/27/2011	US20110262558 Composition For Skin Sanitization And Protection And Method Of Its Use
10/27/2011	US20110262556 Silver/water, silver gels and silver-based compositions; and methods for making and using the same
10/27/2011	US20110262553 Compositions Suitable For Treating Cutaneous Signs Of Aging
10/27/2011	US20110262550 Method for treating a skin ailment
10/27/2011	US20110262541 Foam-formed collagen strand
10/27/2011	US20110262531 Nanoparticulate system, process for the preparation of the same, use of the same, photoprotective composition, process for the preparation of the same, method of prevention of diseases of the skin
10/27/2011	US20110262523 medical adhesive tape and medical articles made of the same
10/27/2011	US20110262521 Medical device including bacterial cellulose reinforced by resorbable or non resorbable reinforcing materials
10/27/2011	US20110262516 Autologous cells on a support matrix for tissue repair
10/27/2011	US20110262515 Fenestrated wound repair scaffold
10/27/2011	US20110262511 Novel Uses
10/27/2011	US20110262506 Topical compositions containing coated active agents
10/27/2011	US20110262499 Topical herbal formulation for treatment of acne and skin disorders
10/27/2011	US20110262489 Hyaluronic acid cryogel - compositions, uses, processes for manufacturing
10/27/2011	US20110262451 Modulators of isovaleryl-coenzyme a dehydrogenase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011	US20110262450 Modulators of monoglyceride lipase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011	US20110262449 Method for the treatment of gout or pseudogout
10/27/2011	US20110262445 Anti-il-12/il-23 antibodies

1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 1065